Your browser doesn't support javascript.
loading
Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.
Liu, Mengyao; Wang, Shenglong; Liang, Yujiao; Fan, Yongsheng; Wang, Weijie.
Afiliação
  • Liu M; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Wang S; The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Liang Y; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
  • Fan Y; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, China.
  • Wang W; Department of Rheumatology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310005, China. jack1987168@163.com.
Clin Rheumatol ; 43(8): 2403-2416, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38963465
ABSTRACT
Systemic lupus erythematosus (SLE) is a common autoimmune disease with a polymorphic clinical presentation involving multisystem damages with significant differences in prevalence and disease severity among different ethnic groups. Although genetic, hormonal, and environmental factors have been demonstrated to contribute a lot to SLE, the pathogenesis of SLE is still unknown. Numerous evidence revealed that gene variants within the type I interferons (IFN) signaling pathway performed the great genetic associations with autoimmune diseases including SLE. To date, through genome-wide association studies (GWAS), genetic association studies showed that more than 100 susceptibility genes have been linked to the pathogenesis of SLE, among which TYK2, STAT1, STAT4, and IRF5 are important molecules directly connected to the type I interferon signaling system. The review summarized the genetic associations and the detailed risk loci of STAT4 and IRF5 with Asian SLE patients, explored the genotype distributions associated with the main clinical manifestations of SLE, and sorted out the potential reasons for the differences in susceptibility in Asia and Europe. Moreover, the therapies targeting STAT4 and IRF5 were also evaluated in order to propose more personalized and targeted treatment plans in SLE.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Predisposição Genética para Doença / Povo Asiático / Fatores Reguladores de Interferon / Fator de Transcrição STAT4 / Estudo de Associação Genômica Ampla / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Revista: Clin Rheumatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: ALEMANHA / ALEMANIA / DE / DEUSTCHLAND / GERMANY

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Predisposição Genética para Doença / Povo Asiático / Fatores Reguladores de Interferon / Fator de Transcrição STAT4 / Estudo de Associação Genômica Ampla / Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Revista: Clin Rheumatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: ALEMANHA / ALEMANIA / DE / DEUSTCHLAND / GERMANY